Open Procurement Albania

Loti 69 Oxaliplatin

Contracted Institution Ministry of Health
Tenderer Institution Ministry of Health
Tender object B1-Blerje barna Anti-infektive të përgjithshëm, Anestezi Reanimacion, Antituberkulare, Antineoplastike dhe immunomodulatore, antiparazitare, dermatologjike, hormonale sistemike, hormonet seksuale, Gjaku dhe organet formuese të gjakut dhe Sistemi Respirator.

Loti 69 Oxaliplatin

Burimi i Financimit: Buxheti i shtetit.
Reference No. REF-49480-02-05-2020
Estimated / Ceiling Value ALL without VAT 30 741 193,00
Type of Contract
Procurement Method Open Procedure above the high monetary limit
Stage Procedure Announced the Winner
Tender Publication Date 06-02-2020
Last date of Submitted Documents 24-03-2020
Tender Held Date 24-03-2020
No. of Bidders 4
Bidders REJSI-FARMA
DELTA PHARMA-AL
MEGAPHARM
ALBANIA NEW FARM
Successful Bidder /Supplier / Provider
  • Rejsi FARMA SHPK
  • The winning bid ALL without vat 1,389.65  leke per njesi
    Bidder Announcement date 03-06-2020
    Award and Contract Amount ALL with VAT
    Contract date
    Planned Milestones of Contract / Start and End Date Kontratat mund te lidhen nga AK perfituese brenda afatit 24 muaj nga data e neshkrimit te MK nga palet, për secilin lot.
    Renewal Contract Additional Value (ALL with VAT)
    Appeals Nuk ka pasur ankesa.
    Cancellation reason
    Additions
    Transaction / Actual Spending
  • Monitor treasury transaction for Rejsi FARMA SHPK viti 2012-2013
    Monitor treasury transaction for Rejsi FARMA SHPK viti 2014
    Monitor treasury transaction for Rejsi FARMA SHPK viti 2015-2018
    Monitor treasury transaction for Rejsi FARMA SHPK viti 2019-2020
  • Public Announcement Bulletin Contracts signed under the Framework Agreement Ministria e Shëndetësisë REF-49480-02-05-2020
    Announcement of Procurement Nr. 5 datë 10 Shkurt 2020
    Standard Tender Documents
    Bidder Announcement
    Signing of the Contract
    Modifikim DST (I)

    Modifikim DST (II)

    Aneks Shperndarjeje

    Contact Notification - Financial Times